Endurance Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.86M | Buy |
26,941
+1,540
| +6% | +$110K | 0.25% | 72 |
|
|
2023
Q1 | $1.89M | Buy |
25,401
+1,560
| +7% | +$131K | 0.27% | 68 |
|
|
2022
Q4 | $2.22M | Buy |
23,841
+40
| +0.2% | +$3.86K | 0.33% | 62 |
|
|
2022
Q3 | $2.27M | Sell |
23,801
-236
| -1% | -$23.4K | 0.37% | 58 |
|
|
2022
Q2 | $2.23M | Sell |
24,037
-776
| -3% | -$75.7K | 0.34% | 66 |
|
|
2022
Q1 | $2.51M | Sell |
24,813
-29
| -0.1% | -$3.05K | 0.32% | 63 |
|
|
2021
Q4 | $2.56M | Sell |
24,842
-50
| -0.2% | -$4.62K | 0.28% | 76 |
|
|
2021
Q3 | $2.11M | Sell |
24,892
-181
| -0.7% | -$15.2K | 0.23% | 88 |
|
|
2021
Q2 | $2.09M | Sell |
25,073
-550
| -2% | -$45K | 0.23% | 86 |
|
|
2021
Q1 | $1.93M | Sell |
25,623
-300
| -1% | -$21.9K | 0.23% | 85 |
|
|
2020
Q4 | $1.77M | Sell |
25,923
-698
| -3% | -$45.4K | 0.22% | 83 |
|
|
2020
Q3 | $1.55M | Buy |
26,621
+224
| +0.8% | +$13.9K | 0.23% | 82 |
|
|
2020
Q2 | $1.72M | Buy |
26,397
+326
| +1% | +$20.5K | 0.28% | 75 |
|
|
2020
Q1 | $1.55M | Buy |
26,071
+1,000
| +4% | +$66.8K | 0.3% | 70 |
|
|
2019
Q4 | $1.86M | Sell |
25,071
-327
| -1% | -$23K | 0.29% | 73 |
|
|
2019
Q3 | $1.6M | Sell |
25,398
-689
| -3% | -$40.8K | 0.27% | 77 |
|
|
2019
Q2 | $1.42M | Sell |
26,087
-50,641
| -66% | -$2.73M | 0.22% | 79 |
|
|
2019
Q1 | $4.14M | Buy |
76,728
+17,701
| +30% | +$1.09M | 0.68% | 48 |
|
|
2018
Q4 | $3.87M | Sell |
59,027
-27,234
| -32% | -$2.03M | 0.72% | 42 |
|
|
2018
Q3 | $6.79M | Buy |
86,261
+14,600
| +20% | +$1.04M | 1.07% | 29 |
|
|
2018
Q2 | $4.61M | Sell |
71,661
-1,671
| -2% | -$110K | 0.76% | 44 |
|
|
2018
Q1 | $4.56M | Sell |
73,332
-6,395
| -8% | -$459K | 0.77% | 42 |
|
|
2017
Q4 | $5.78M | Sell |
79,727
-36,701
| -32% | -$2.67M | 0.93% | 33 |
|
|
2017
Q3 | $9.47M | Buy |
116,428
+1,158
| +1% | +$91.6K | 1.57% | 19 |
|
|
2017
Q2 | $9.28M | Buy |
115,270
+8,160
| +8% | +$644K | 1.57% | 20 |
|
|
2017
Q1 | $8.41M | Buy |
107,110
+10,233
| +11% | +$817K | 1.45% | 21 |
|
|
2016
Q4 | $7.64M | Buy |
96,877
+359
| +0.4% | +$29K | 1.37% | 23 |
|
|
2016
Q3 | $8.38M | Buy |
96,518
+2,371
| +3% | +$224K | 1.5% | 20 |
|
|
2016
Q2 | $9.01M | Sell |
94,147
-2,625
| -3% | -$262K | 1.69% | 13 |
|
|
2016
Q1 | $10K | Buy |
96,772
+932
| +1% | +$90.6K | 1.41% | 8 |
|
|
2015
Q4 | $9.37M | Buy |
95,840
+6,846
| +8% | +$670K | 1.79% | 15 |
|
|
2015
Q3 | $9.17M | Sell |
88,994
-231
| -0.3% | -$24.3K | 1.61% | 15 |
|
|
2015
Q2 | $9.36M | Sell |
89,225
-1,161
| -1% | -$119K | 1.57% | 13 |
|
|
2015
Q1 | $9.33M | Sell |
90,386
-1,025
| -1% | -$104K | 1.63% | 13 |
|
|
2014
Q4 | $8.8M | Sell |
91,411
-50
| -0.1% | -$4.41K | 1.58% | 17 |
|
|
2014
Q3 | $7.28M | Buy |
91,461
+2,624
| +3% | +$207K | 1.36% | 22 |
|
|
2014
Q2 | $6.7M | Buy |
88,837
+3,525
| +4% | +$266K | 1.12% | 27 |
|
|
2014
Q1 | $6.39M | Buy |
85,312
+12,646
| +17% | +$893K | 1.24% | 25 |
|
|
2013
Q4 | $5.2M | Sell |
72,666
-297
| -0.4% | -$19.1K | 1.03% | 33 |
|
|
2013
Q3 | $4.14M | Buy |
72,963
+925
| +1% | +$55.1K | 0.88% | 37 |
|
|
2013
Q2 | $4.12M | Buy |
+72,038
| New | +$4.17M | 0.92% | 36 |
|
Other funds holding CVS
Endurance Wealth Management's CVS Position: Q2 2023 in Review
Endurance Wealth Management increased its CVS Health (CVS) stake by 6.1% in Q2 2023, buying an estimated $110K and bringing the position to 26,941 shares worth $1.86M. The position accounts for 0.25% of the portfolio, ranked #72.
Endurance Wealth Management first reported a position in CVS in Q2 2013 and has held it in 41 quarters since. The position peaked at $9.47M in Q3 2017. 2,204 funds tracked by Wall St. Rank hold CVS as of Q2 2023.
- Endurance Wealth Management held 26,941 shares of CVS Health worth $1.86M as of Q2 2023.
- Endurance Wealth Management bought 1,540 CVS Health shares in Q2 2023, an estimated $110K.
- CVS Health made up 0.25% of Endurance Wealth Management's portfolio in Q2 2023, its #72 holding.
- Endurance Wealth Management first reported a position in CVS Health in Q2 2013 and has held it in 41 quarters since.
- Endurance Wealth Management's CVS Health position peaked at $9.47M in Q3 2017.
- 2,204 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.
Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.